Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: NANOMATRONIX LLC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-09-22 to 2025-01-21
Current total value of award: $1099993.64
Description: AWARD OF NANOMATRONIX'S DHA SBIR SEQUENTIAL PHASE II MEDICAL R&D CONTRACT FOR "THE AMBIT PLATFORM: AN IN VITRO SYSTEM FOR TRAUMATIC BRAIN INJURY R&D", PROPOSAL NO. H2-0710.